House of Commons portcullis
House of Commons
Session 1999-2000
Publications on the internet
Health Committee Publications

Health - Minutes of Evidence [Back to Report]

Here you can browse the Minutes of Evidence which were ordered by the House of Commons to be printed 13 January 2000.


THURSDAY 13 JANUARY 2000



Members present:


Mr David Hinchliffe, in the Chair
Mr David AmessMr John Gunnell
Mr John AustinMr Stephen Hesford
Dr Peter BrandDr Howard Stoate
Mr Simon BurnsAudrey Wise
Mrs Eileen Gordon






CONTENTS

Memorandum by British American Tobacco


EXECUTIVE SUMMARY


THE BRITISH AMERICAN TOBACCO GROUP OF COMPANIES


UK INDUSTRY RESEARCH


BRITISH AMERICAN TOBACCO'S OWN RESEARCH


ROTHMANS' OWN RESEARCH


GOVERNMENT'S ROLE IN THE DEVELOPMENT OF LOWER RISK CIGARETTES


COMPENSATION


NICOTINE AND ADDICTION


INGREDIENTS


ENVIRONMENTAL TOBACCO SMOKE


SMOKING AND YOUNG PEOPLE


ADVERTISING AND CONSUMER PROTECTION


RELATIVE RISK AND AMOUNT SMOKED


THE ROLE OF GOVERNMENT



Memorandum by Gallaher Group Plc


1.Summary


2.Foreword


3.Gallaher Group Plc


4.Smoking and Health


5.Public Awareness


6.Relationship with Government


7.Appendix 1—The composition of a cigarette and its smoke


8.Appendix 2—The history of the public awareness of the risks associated with smoking


9.Appendix 3—Summary of voluntary agreements and key provisions



Memorandum by Imperial Tobacco Group PLC

Summary

Introduction

Scientific research into smoking and health

Imperial's product modification initiatives

Co-operation with Government

Smoking: A matter for informed adult choice

The way forward


Letter from the Corporate Affairs Director Imperial Tobacco Group PLC (TB 13B)


Memorandum by Philip Morris Europe SA


APPENDIX A


Memorandum by R J Reynolds Tobacco (UK) Limited


APPENDIX



Examination of Witnesses

MR MARTIN BROUGHTON, Chairman, British American Tobacco, MR PETER WILSON, Executive Chairman, Gallaher Group plc, MR GARETH DAVIS, Chief Executive, Imperial Tobacco Group plc, MR DAVID DAVIES, Vice President, Corporate Affairs, Philip Morris Europe, and DR AXEL GIETZ, Vice President, RJ Reynolds Tobacco (UK) Limited, were examined.

Question Number

384 - 399

400 - 419

420 - 439

440 - 459

460 - 479

480 - 499

500 - 519

520 - 539

540 - 559

560 - 579

580 - 599

600 - 609


 
contents next page

House of Commons home page Parliament home page House of Lords home page search page enquiries

© Parliamentary copyright 2000
Prepared 28 February 2000